Paper Review Records
All Paper Review Records
6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Autologous chondrocyte implantation for the knee: Historical development, age-related outcomes, and future directions
Kyohei Nakata; Akinori Nekomoto; Atsuo Nakamae; Nobuo AdachiShow moreShow less
1. Department of Orthopaedic Surgery, Graduate School of Biomedical & Health Sciences, Hiroshima University , Hiroshima ,; 2. Department of Musculoskeletal Reconstruction and Biomaterials, Graduate School of Biomedical & Health Sciences, Hiroshima University , Hiroshima ,Show moreShow less
The evolutionary trade-off between immunosurveillance and self-tolerance: Insights from four rheumatologic themes
Masaru Kato; Masatoshi Kawataka; Satoshi Yamaguchi; Reina Tsuda; Yoshitomo Morinaga; Tatsuhiko Ozawa; Shiho FujisakaShow moreShow less
1. The First Department of Internal Medicine, Faculty of Medicine, University of Toyama , Toyama ,; 2. Department of Rheumatology and Kampo Medicine, Toyama Prefectural Central Hospital , Toyama ,; 3. Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,; 4. Department of Life Sciences and Bioengineering, Laboratory of Molecular and Cellular Biology, Faculty of Engineering, Academic Assembly, University of Toyama , Toyama ,; 5. Center for Advanced Antibody Drug Development, University of Toyama , Toyama ,Show moreShow less
Exploring brain metabolism and cognitive impairment in childhood-onset systemic lupus using fluorodeoxyglucose positron emission tomography
Flávia Patrícia Sena Teixeira Santos; Gilda Aparecida Ferreira; Alexei Manso Machado; Jonas Jardim de Paula; Kalline Cristina Prata De Souza; Lucas Teles de Carvalho Godoy Sampaio; Marcelo Mamede; Carlos Malamut; Humberto CorreaShow moreShow less
1. Division of Rheumatology, Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 2. Department of the Locomotor Apparatus, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 3. Department of Anatomy and Imaging, School of Medicine, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 4. Department of Psychology, Faculdade de Ciências Médicas de Minas Gerais , Belo Horizonte ,; 5. Department of the Locomotor Apparatus, Post graduation Program in Molecular Medicine, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,; 6. Department of Psychology, Faculdade de Ciências Médicas de Minas Gerais, Nuclear Technology Development Center, Nuclear Energy National Commission (CDTN/CNEN) ,; 7. Department of Mental Health, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte ,Show moreShow less
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study
Tsutomu Takeuchi; Ronald van Vollenhoven; Yukitaka Ueki; Tatsuya Atsumi; Sebastian Meerwein; Xianwei Bu; Kazuya Hirata; Vibeke StrandShow moreShow less
1. Keio University School of Medicine , Tokyo ,; 2. Saitama Medical University , Saitama ,; 3. Amsterdam University Medical Center , Amsterdam ,; 4. Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital , Sasebo, Nagasaki ,; 5. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University , Sapporo ,; 6. AbbVie Inc. , North Chicago, IL ,; 7. AbbVie GK , Tokyo ,; 8. Division of Immunology and Rheumatology, Stanford University , Palo Alto, CA ,Show moreShow less
Patient-reported outcomes in patients with rheumatoid arthritis treated with baricitinib: A prospective observational study in Japan
Yuko Kaneko; Naoto Tsujimoto; Izumi Sato; Taisuke Kojima; Kei IkedaShow moreShow less
1. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine , 35 Shinanomachi, Shinjuku-ku, Tokyo ,; 2. Japan Drug Development & Medical Affairs, Eli Lilly Japan K.K. , Kobe ,; 3. Department of Rheumatology/Rheumatic Disease Center, Dokkyo Medical University , 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi ,Show moreShow less
Decrease of Infectious Complications in Outpatients With Autoimmune Diseases From 2019 to 2020 Under the COVID-19 Pandemic: A Single-Center, Retrospective Cohort Study in Japan
Yumiko Oka; Takao Kodera; Miki Takeshita; Yuko Shirota; Tomoki Takeda; Tomomi Tsutsumi; Junichi KameokaShow moreShow less
1. Department of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, JapanShow moreShow less
FAQ
How long does Modern Rheumatology take to review a manuscript?
As of 2026-11-19, CrushSCI has 6 complete review records for Modern Rheumatology. The fastest paper went from submission to acceptance in 22 days (Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study, received 2026-02-12, accepted 2026-03-06); the slowest took 208 days. The average is 111.3 days and the median is 92 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
